PROM1 and neoplasm: Subsequently, isolation based upon CD133 positivity had revealed tumor-initiating cells in some neoplasms such as leukemia[4], brain cancer[5], ovarian cancer[6], hepatocellular carcinoma[7], prostate[8] and pancreas[9].